Treatment pathways defined as the sequence of visits to the public health system of patients with cardiomyopathies in Poland in the period 2016-2021

Kardiol Pol. 2024;82(5):500-506. doi: 10.33963/v.phj.100178. Epub 2024 Apr 12.

Katarzyna Mizia-Stec^{1

2}, Jacek Grzybowski³, Urszula Cegłowska^{4

5}, Anna Wiśniewska⁴, Kacper Hałgas⁴, Maciej Wybraniec^{6

7}, Olaf Pachciński^{6

7}, Maria Stec^{6

7}, Daniel Cieśla⁸, Mariusz Gąsior⁸, Tomasz Hryniewiecki⁹, Przemysław Leszek¹⁰

¹ Department of Cardiology, 1st Chair of Cardiology, Medical University of Silesia in Katowice. kmiziastec@gmail.com.
² European Reference Network of Heart Diseases (ERN GUARD-HEART). kmiziastec@gmail.com.
³ Department of Cardiomyopathy, National Institute of Cardiology, Warszawa, Poland.
⁴ Department of Analysis and Strategy, Ministry of Health of the Republic of Poland.
⁵ Department of Epidemiology and Health Promotion, School of Public Health, Centre of Postgraduate Medical Education, Warszawa, Poland.
⁶ Department of Cardiology, 1st Chair of Cardiology, Medical University of Silesia in Katowice.
⁷ European Reference Network of Heart Diseases (ERN GUARD-HEART).
⁸ 3rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Silesian Center for Heart Diseases, Medical University of Silesia, Katowice, Poland.
⁹ Department of Valvular Cardiac Defects, National Institute of Cardiology, Warszawa, Poland.
¹⁰ Department of Heart Failure and Transplantology, Mechanical Circulatory Support and Heart Transplant Unit, National Institute of Cardiology, Warszawa, Poland.

No abstract available

MeSH terms